Who is FILLMED?
FILLMED Medical by Filorga (originally Filorga Medical), was founded in 1978 by Michel Tordjman, a French doctor of aesthetic medicine, with a fascination for cellular biology. Michel Tordjman pioneered NCTF® , New Cellular Treatment Factor, a unique injectable solution that prevents, slows and corrects the effects of skin ageing.
Dr Tordjman’s innovations were originally intended to provide dermatologists and doctors of aesthetic medicine with an extensive range of treatment solutions: peeling treatments, hyaluronic acid for mesotherapy and prescription skincare Skin Perfusion
NCTF® BOOST family of hydrators now constitutes an undisputed skin rejuvenation benchmark. It is regularly cited in medical articles and other professional publications around the world. This unique compound comprises more than 50 active ingredients. It recreates an ideal cellular ecosystem and boosts the factors required for beautiful skin.
+ 147% Increase in fibroblast stimulation*
+ 256% Increase in collagen stimulation*
+ 90% Reduction in free radicals*
With over 3 million bottles sold, NCTF® family of hydrators is now the leading polyrevitalising agent used in mesotherapy
and topical hydration treatments throughout the world; the compound is cited in numerous medical reviews
and is discussed widely at medical congresses.
Register for a FILLMED account today to access marketing materials, videos, product images, consent forms, training and more!
*In Australia the cosmetic NCTF® BOOST 135HA is available for topical application.
Inquiries for New Zealand including FILLMED medical devices please contact the Cryomed team.